R1 RCM (RCM) Scheduled to Post Quarterly Earnings on Wednesday

R1 RCM (NASDAQ:RCM) is scheduled to post its quarterly earnings results before the market opens on Wednesday, May 8th. Analysts expect R1 RCM to post earnings of ($0.05) per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

R1 RCM Stock Up 0.2 %

R1 RCM stock opened at $12.47 on Monday. The stock’s 50 day moving average is $12.98 and its 200 day moving average is $11.43. R1 RCM has a one year low of $8.87 and a one year high of $18.70. The company has a quick ratio of 1.83, a current ratio of 1.83 and a debt-to-equity ratio of 0.57.

Insider Buying and Selling

In other news, President John M. Sparby sold 10,046 shares of the business’s stock in a transaction dated Thursday, March 7th. The stock was sold at an average price of $14.33, for a total transaction of $143,959.18. Following the completion of the transaction, the president now owns 265,986 shares of the company’s stock, valued at $3,811,579.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 36.80% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on RCM. Cantor Fitzgerald reissued an “overweight” rating and issued a $20.00 price objective on shares of R1 RCM in a research report on Wednesday, April 10th. Barclays reissued an “equal weight” rating and issued a $14.00 price target on shares of R1 RCM in a research note on Wednesday, February 28th. Citigroup raised shares of R1 RCM from a “neutral” rating to a “buy” rating and set a $16.00 price objective for the company in a research report on Wednesday, March 20th. Guggenheim lowered their price objective on shares of R1 RCM from $17.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, April 5th. Finally, Morgan Stanley reissued an “overweight” rating and set a $17.00 target price on shares of R1 RCM in a research note on Tuesday, March 26th. Five research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $16.87.

About R1 RCM

R1 RCM Inc provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers.